It won’t stop with melanoma. Yes, you read that right. That’s the beauty of commercial leaps. They beget copious investment in search of the advances given life by the original advance.
As readers already know well, and as was discussed here last week, Moderna’s long-term collaboration with Merck has resulted in a vaccine for melanoma. While it’s not yet seen as a certain cure for the would-be killer, the vaccine is seen as effective when it comes to keeping melanoma from returning or spreading.
Read Full Article »
